GB201610440D0 - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
GB201610440D0
GB201610440D0 GBGB1610440.8A GB201610440A GB201610440D0 GB 201610440 D0 GB201610440 D0 GB 201610440D0 GB 201610440 A GB201610440 A GB 201610440A GB 201610440 D0 GB201610440 D0 GB 201610440D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1610440.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Midatech Ltd
Original Assignee
Midatech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Midatech Ltd filed Critical Midatech Ltd
Priority to GBGB1610440.8A priority Critical patent/GB201610440D0/en
Publication of GB201610440D0 publication Critical patent/GB201610440D0/en
Priority to ES17715654T priority patent/ES2743740T3/en
Priority to PL17715654T priority patent/PL3347055T3/en
Priority to US16/081,694 priority patent/US10722597B2/en
Priority to CN201780021581.9A priority patent/CN109310783B/en
Priority to PCT/EP2017/057472 priority patent/WO2017167837A1/en
Priority to KR1020187029287A priority patent/KR102416050B1/en
Priority to JP2018550588A priority patent/JP6880058B2/en
Priority to EP17715654.4A priority patent/EP3347055B1/en
Priority to PT17715654T priority patent/PT3347055T/en
Priority to AU2017242544A priority patent/AU2017242544B2/en
Priority to BR112018069901A priority patent/BR112018069901A2/en
Priority to CA3018923A priority patent/CA3018923A1/en
Priority to MX2018011760A priority patent/MX2018011760A/en
Priority to US16/899,408 priority patent/US11235068B2/en
Priority to AU2023201091A priority patent/AU2023201091A1/en
Ceased legal-status Critical Current

Links

GBGB1610440.8A 2016-03-31 2016-06-15 Pharmaceutical formulations Ceased GB201610440D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB1610440.8A GB201610440D0 (en) 2016-06-15 2016-06-15 Pharmaceutical formulations
MX2018011760A MX2018011760A (en) 2016-03-31 2017-03-29 Cyclodextrin-panobinostat adduct.
KR1020187029287A KR102416050B1 (en) 2016-03-31 2017-03-29 Cyclodextrin-panobinostat adduct
EP17715654.4A EP3347055B1 (en) 2016-03-31 2017-03-29 Cyclodextrin-panobinostat adduct
US16/081,694 US10722597B2 (en) 2016-03-31 2017-03-29 Cyclodextrin-panobinostat adduct
CN201780021581.9A CN109310783B (en) 2016-03-31 2017-03-29 Cyclodextrin-panobinostat adducts
PCT/EP2017/057472 WO2017167837A1 (en) 2016-03-31 2017-03-29 Cyclodextrin-panobinostat adduct
ES17715654T ES2743740T3 (en) 2016-03-31 2017-03-29 Cyclodextrin-panobinostat adduct
JP2018550588A JP6880058B2 (en) 2016-03-31 2017-03-29 Cyclodextrin-panobinostat adduct
PL17715654T PL3347055T3 (en) 2016-03-31 2017-03-29 Cyclodextrin-panobinostat adduct
PT17715654T PT3347055T (en) 2016-03-31 2017-03-29 Cyclodextrin-panobinostat adduct
AU2017242544A AU2017242544B2 (en) 2016-03-31 2017-03-29 Cyclodextrin-panobinostat adduct
BR112018069901A BR112018069901A2 (en) 2016-03-31 2017-03-29 cyclodextrin-panobinostat adduct
CA3018923A CA3018923A1 (en) 2016-03-31 2017-03-29 Cyclodextrin-panobinostat adduct for treating brain tumours
US16/899,408 US11235068B2 (en) 2016-03-31 2020-06-11 Cyclodextrin-panobinostat adduct
AU2023201091A AU2023201091A1 (en) 2016-03-31 2023-02-23 Cyclodextrin-Panobinostat Adduct

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1610440.8A GB201610440D0 (en) 2016-06-15 2016-06-15 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
GB201610440D0 true GB201610440D0 (en) 2016-07-27

Family

ID=56894887

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1610440.8A Ceased GB201610440D0 (en) 2016-03-31 2016-06-15 Pharmaceutical formulations

Country Status (1)

Country Link
GB (1) GB201610440D0 (en)

Similar Documents

Publication Publication Date Title
IL246978A0 (en) Novel pharmaceutical formulations
SI4070788T1 (en) Pharmaceutical formulations
HK1254343A1 (en) Pharmaceutical formulations
ZA201903101B (en) Pharmaceutical formulations
IL262745A (en) Improved drug formulations
PT3426294T (en) Pharmaceutical formulation
GB201608323D0 (en) Pharmaceutical compositions
IL253177B (en) Pharmaceutical formulation
HK1245653A1 (en) Pharmaceutical formulation
ZA201707094B (en) Pharmaceutical formulations
IL266537A (en) Pharmaceutical formulation
EP3337463A4 (en) Pharmaceutical formulations
ZA201807851B (en) Pharmaceutical formulation
GB201506755D0 (en) Novel pharmaceutical formulation
GB201611920D0 (en) Pharmaceutical compositions
IL271908A (en) Hypercompressed pharmaceutical formulations
GB201511246D0 (en) Pharmaceutical formulation
GB201417589D0 (en) Pharmaceutical Formulations
GB201610440D0 (en) Pharmaceutical formulations
GB201700831D0 (en) Pharmaceutical compositions
GB201604545D0 (en) Novel pharmaceutical formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)